Answers are grounded in this paper and cite their sources.
INTRODUCTION The renin-angiotensin-aldosterone system (RAAS) is a crucial mechanism by which our bodies maintain blood pressure and fluid & electrolyte balance. Any disruption to this system may upset the carefully maintained equilibrium, leading to development of hypertension and cardiovascular (CV) diseases. Thus, RAAS has been a key therapeutic target in hypertension since the serendipity discovery of angiotensin converting enzyme inhibitors (ACEis) in the 1970s. The use of ACEis have also evolved over the decades, from a stand-alone blood pressure (BP) lowering agent to critical underpinnings of CV protection in high-risk patients following improved elucidation of its role.
No takes yet. Share an insight, caveat, or question.
Vijaya Bharath Ramasamy (2023) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: